Waseem Summaiyya, Ahmed Syed Hassan, Fatima Sharmeen, Shaikh Taha Gul, Ahmed Jawad
Dow University of Health Sciences, Karachi, Pakistan.
Ann Med Surg (Lond). 2022 Sep;81:104472. doi: 10.1016/j.amsu.2022.104472. Epub 2022 Aug 28.
In 2019, the discovery of a new strain of Coronavirus, later referred to as SARS-CoV2 took the world by storm, leading to a pandemic and shutting down all global activities. Several measures were taken adequately to combat the viral havoc, including developing numerous vaccines. All the vaccines currently available for the general population went through rigorous screenings and trials to ensure maximum safety and were only approved after that. However, once they were rolled out in the markets and administered to the population, some adverse reactions were reported, one of which included uveitis. It is an ocular inflammatory condition of the uveal tract, choroid, or iris. If untreated, it can lead to severe consequences, including blindness. It is further divided into four categories based on its anatomical location. Despite the rare incidence of uveitis following COVID-19 vaccination, it may contribute to vaccine hesitancy; hence addressing and digging into the pathophysiological cause is crucial. This study evaluates all the pathophysiological and demographical links between COVID-19 vaccination and uveitis, suggesting appropriate management plans.
2019年，一种新型冠状病毒毒株（后来被称为严重急性呼吸综合征冠状病毒2）的发现震惊了世界，引发了一场大流行并导致所有全球活动停摆。人们采取了多项充分措施来对抗病毒的破坏，包括研发多种疫苗。目前面向普通人群的所有疫苗都经过了严格的筛查和试验，以确保最大程度的安全性，并且只有在此之后才获得批准。然而，一旦它们在市场上推出并接种给人群，就有一些不良反应被报告，其中之一包括葡萄膜炎。它是葡萄膜、脉络膜或虹膜的一种眼部炎症性疾病。如果不治疗，可能会导致严重后果，包括失明。根据其解剖位置，它进一步分为四类。尽管新冠疫苗接种后葡萄膜炎的发病率很低，但它可能会导致疫苗犹豫；因此，找出并深入研究其病理生理原因至关重要。本研究评估了新冠疫苗接种与葡萄膜炎之间的所有病理生理和人口统计学联系，并提出了适当的管理计划。
